JP2007509955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509955A5 JP2007509955A5 JP2006538213A JP2006538213A JP2007509955A5 JP 2007509955 A5 JP2007509955 A5 JP 2007509955A5 JP 2006538213 A JP2006538213 A JP 2006538213A JP 2006538213 A JP2006538213 A JP 2006538213A JP 2007509955 A5 JP2007509955 A5 JP 2007509955A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- methionine
- protective agent
- administration
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003223 protective agent Substances 0.000 claims 11
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 8
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- 229960004452 methionine Drugs 0.000 claims 5
- 230000005855 radiation Effects 0.000 claims 5
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- 230000000259 anti-tumor effect Effects 0.000 claims 4
- 239000002246 antineoplastic agent Substances 0.000 claims 4
- 230000000973 chemotherapeutic effect Effects 0.000 claims 4
- 238000002512 chemotherapy Methods 0.000 claims 4
- 229910052697 platinum Inorganic materials 0.000 claims 4
- 230000037380 skin damage Effects 0.000 claims 4
- 229930195722 L-methionine Natural products 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229930182818 D-methionine Natural products 0.000 claims 2
- 206010040844 Skin exfoliation Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 230000035618 desquamation Effects 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- MIQJGZAEWQQAPN-YFKPBYRVSA-N (2s)-2-amino-4-methylsulfanylbutan-1-ol Chemical compound CSCC[C@H](N)CO MIQJGZAEWQQAPN-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims 1
- 125000000296 D-methionine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C([H])([H])SC([H])([H])[H] 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 claims 1
- SFSJZXMDTNDWIX-YFKPBYRVSA-N L-homomethionine Chemical compound CSCCC[C@H](N)C(O)=O SFSJZXMDTNDWIX-YFKPBYRVSA-N 0.000 claims 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 claims 1
- 206010028116 Mucosal inflammation Diseases 0.000 claims 1
- 201000010927 Mucositis Diseases 0.000 claims 1
- 206010042496 Sunburn Diseases 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- SFSJZXMDTNDWIX-UHFFFAOYSA-N homomethionine Natural products CSCCCC(N)C(O)=O SFSJZXMDTNDWIX-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- -1 normethionine Chemical compound 0.000 claims 1
- 239000011251 protective drug Substances 0.000 claims 1
- 208000003265 stomatitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/694,436 US20050090551A1 (en) | 2003-10-27 | 2003-10-27 | Therapeutic use of methionine for the treatment or prevention of mucositis |
| US10/694,436 | 2003-10-27 | ||
| PCT/US2004/035626 WO2005039554A2 (en) | 2003-10-27 | 2004-10-27 | Therapeutic use of methionine for the treatment or prevention of mucositis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509955A JP2007509955A (ja) | 2007-04-19 |
| JP2007509955A5 true JP2007509955A5 (https=) | 2007-12-06 |
| JP4884974B2 JP4884974B2 (ja) | 2012-02-29 |
Family
ID=34522601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538213A Expired - Fee Related JP4884974B2 (ja) | 2003-10-27 | 2004-10-27 | 粘膜炎の予防及び処置のためのメチオニンの治療上の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050090551A1 (https=) |
| EP (1) | EP1677775B1 (https=) |
| JP (1) | JP4884974B2 (https=) |
| AT (1) | ATE536178T1 (https=) |
| AU (1) | AU2004283756B2 (https=) |
| CA (1) | CA2543870C (https=) |
| ES (1) | ES2376102T3 (https=) |
| WO (1) | WO2005039554A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071230B2 (en) * | 1997-10-02 | 2006-07-04 | Board Of Trustees Of Southern Illinois University | Therapeutic use of D-methionine to reduce the toxicity of noise |
| CN101453985A (zh) * | 2006-03-28 | 2009-06-10 | 诺华丝国际股份有限公司 | 促进毛发生长的组合物 |
| GB0704718D0 (en) * | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| KR20200075044A (ko) | 2008-01-22 | 2020-06-25 | 아라임 파마슈티칼즈, 인크. | 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체 |
| JP2011514349A (ja) | 2008-03-07 | 2011-05-06 | サイドース・エルエルシー | フルベストラント配合物 |
| EP2478899B1 (en) * | 2009-09-14 | 2018-05-09 | Shiseido Company, Ltd. | Composition for alleviating ultraviolet irradiation-induced damage |
| EP2484353A4 (en) * | 2009-09-30 | 2013-04-17 | Shiseido Co Ltd | ORAL ACCEPTABLE COMPOSITION FOR TREATMENT BY ULTRAVIOLETTREADING OF INDIRECT DAMAGES |
| US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
| US8541465B2 (en) | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
| US8476310B2 (en) | 2009-10-19 | 2013-07-02 | Scidose Llc | Docetaxel formulations with lipoic acid |
| US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
| JP5578997B2 (ja) * | 2010-09-16 | 2014-08-27 | 国立大学法人 大分大学 | がん化学療法誘発脱毛に対する抗脱毛用組成物 |
| US11179468B2 (en) | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
| WO2020036975A1 (en) * | 2018-08-14 | 2020-02-20 | Tosk, Inc. | Methods and compositions for reducing fluorouracil induced toxicity |
| US11446303B2 (en) | 2019-06-21 | 2022-09-20 | Tosk, Inc. | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
| EP4178581A4 (en) | 2020-07-07 | 2024-06-05 | Tosk, Inc. | URIDINE PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF LUNG DISEASES |
| CN114051974B (zh) * | 2021-11-10 | 2023-01-17 | 广西医科大学 | 一种肝癌模型及其构建方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652290A (en) * | 1970-08-10 | 1972-03-28 | Merck & Co Inc | Beverages containing stabilized vitamin c |
| US3962429A (en) * | 1973-08-01 | 1976-06-08 | Chugai Seiyaku Kabushiki Kaisha | Method for reducing side effects of aminoglycoside antibiotics and composition therefor |
| US4961926A (en) * | 1987-11-19 | 1990-10-09 | Sloan-Kettering Institute For Cancer Research | Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| US5122369A (en) * | 1990-03-30 | 1992-06-16 | Harmony Health Products, Inc. | Nutrient composition for preventing hair loss |
| MX9700053A (es) * | 1994-07-01 | 1997-04-30 | Procter & Gamble | Composiciones de descamacion. |
| JPH08190187A (ja) * | 1995-01-11 | 1996-07-23 | Canon Inc | 情報記録装置 |
| US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
| US6187817B1 (en) * | 1996-10-03 | 2001-02-13 | Southern Illinois University School Of Medicine | Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| WO1998014182A1 (en) * | 1996-10-03 | 1998-04-09 | Southern Illinois University | Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| DK1053000T3 (da) * | 1998-02-13 | 2008-09-01 | Nutramax Lab Inc | Midler og fremgangsmåder til beskyttelse, behandling og udbedring af bindevæv |
| DE60024268T2 (de) * | 1999-07-13 | 2006-08-03 | Biovitrum Ab | Zusammensetzungen mit stabilem faktor viii |
| ES2282326T3 (es) * | 2000-10-24 | 2007-10-16 | Cis Bio International | Estabilizacion de composiciones radio-farmaceuticas usando tioeteres hidrofilicos o 6-hidroxicromanos hidrofilicos. |
| EP1609468A3 (en) * | 2000-11-22 | 2006-01-25 | Rxkinetix, Inc. | A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis |
| EA006429B1 (ru) * | 2001-03-09 | 2005-12-29 | Сосьете Де Продюи Нестле С.А. | Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения |
| EP1461033B1 (en) * | 2001-11-29 | 2013-02-27 | Sound Pharmaceuticals Incorporated | Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| US20040198841A1 (en) * | 2003-03-13 | 2004-10-07 | Oregon Health & Science University | Use of thiol-based compositions in ameliorating mucosal injury |
| US20060058390A1 (en) * | 2004-09-14 | 2006-03-16 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
-
2003
- 2003-10-27 US US10/694,436 patent/US20050090551A1/en not_active Abandoned
-
2004
- 2004-10-27 AT AT04810055T patent/ATE536178T1/de active
- 2004-10-27 AU AU2004283756A patent/AU2004283756B2/en not_active Ceased
- 2004-10-27 ES ES04810055T patent/ES2376102T3/es not_active Expired - Lifetime
- 2004-10-27 WO PCT/US2004/035626 patent/WO2005039554A2/en not_active Ceased
- 2004-10-27 CA CA2543870A patent/CA2543870C/en not_active Expired - Fee Related
- 2004-10-27 JP JP2006538213A patent/JP4884974B2/ja not_active Expired - Fee Related
- 2004-10-27 EP EP04810055A patent/EP1677775B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509955A5 (https=) | ||
| ES2202834T3 (es) | Uso de d-metionina para reducir la toxicidad de farmacos ototoxicos y ruido. | |
| US20100099766A1 (en) | Topical NSAID compositions having sensate component | |
| AU652946B2 (en) | The pharmacological use of certain cystine derivatives | |
| JP2012510953A5 (https=) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| IL314360A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| BR112020015520A2 (pt) | terapia de combinação para câncer com complexo de anel macrocíclico pentaaza e agente anticâncer à base de platina | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| CA2302568A1 (en) | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| US20050090551A1 (en) | Therapeutic use of methionine for the treatment or prevention of mucositis | |
| BRPI0610873A2 (pt) | tratamento de doenças hepáticas em que o ferro desempenhe um papel na patogênese | |
| CN1582170A (zh) | 扑热息痛的肠胃外组合物 | |
| RU2004133387A (ru) | Фармацевтический препарат с немедленным высвобождением | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JPH11506732A (ja) | 白血病治療薬の製造に関するベンゾイミダゾール類の使用 | |
| CN105246483A (zh) | 用于γ-谷氨酰循环调节的方法和组合物 | |
| JP5161472B2 (ja) | 鎮痛用組成物 | |
| BR0316131A (pt) | Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas por agentes anti-câncer | |
| CN1602192A (zh) | 包含埃坡霉素的组合物及其用于治疗类癌综合征的应用 | |
| RU2007104176A (ru) | Синтез и применение (-)-бета-элемена, (-)-бета-элеменала, (-)-бета-элеменола, фторида (-)-бета-элемена и их аналогов, а также промежуточных продуктов и композитов | |
| AR018198A1 (es) | Soluciones estables de mitoxantrona, procedimiento para prepararlas, utilizacion de dichas soluciones para la preparacion de medicamentos y losmedicamentos de aplicacion de dichas soluciones para el tratamiento de enfermedades cancerosas | |
| US6472381B1 (en) | Method of treating psoriasis | |
| JP2006514063A5 (https=) | ||
| US20020019443A1 (en) | Therapeutic use of D-methionine to reduce the toxicity of noise |